A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to know about symptoms and vaccines.

There are molecular testing gaps in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) treatment, highlighting ...

As part of a person's first line of defense against viruses and other microbes that cause illness and disease, a whole network of proteins and other molecules detect and respond to intruders, which ...

In a paper published last month, researchers at UT Southwestern Medical Center introduced lipid nanoparticles — hollow, fatty ...

Government initiatives promoting healthcare infrastructure development and growing investments in research further support ...

QuidelOrtho’s first quarter results received a strong positive reaction from the market, driven by better-than-expected ...

The Tulane team has developed a handful of other assays for TB detection, including a mass spec test for paucibacillary TB ...

Rohit Kadam turns molecular research into scalable diagnostics that serve frontline clinics, not just publications.

Sabic to close UK cracker, plastics recycler Novoloop raises funds, Kymera strikes molecular glue deal, and more ...

The firm is seeking marketing clearance for its Liaison NES real-time PCR instrument along with a multiplex test for flu A/B, COVID-19, and respiratory syncytial virus infection.

HOLX's Molecular Diagnostics growth stays resilient, as new assays and test adoption offset funding headwinds.

A study published in mBio details the vulnerability of coronaviruses to inhibitors of a small protein domain called Mac1, or the "macrodomain," found in all coronaviruses such as SARS-CoV-2 and ...